Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.
Nervous System Diseases
Deep brain stimulation, stem cell treatment, studying mitochondria—to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.
The SPG is a promising target for migraine treatment, but robust evidence of efficacy for routine use of noninvasive device–mediated SPG blockade is needed.
A new way to treat dementia and other diagnosis and treatment developments are in the news.
A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.
There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.
While a majority of persons with the 4 most common cancers are told the diagnosis, fewer than half of persons with AD get that kind of information. This could be a problem.
An FDA-approved drug for high blood pressure alleviates clinical symptoms of MS in mice, showing great promise for humans.
Focused ultrasound works like a noninvasive knife, cutting away amyloid plaques in mice. But is this new method safe and effective in humans?
Noninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.